License Agreements - Additional Information (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Lilly Agreement | License Fees | |||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
| Accrued liabilities for license fees | $ 43.3 | ||
| Research and Development | |||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
| Contingent obligations and non-royalty sublicense fees | $ 43.5 | $ 2.7 | $ 39.9 |